Reuters logo
BRIEF-Halozyme reports Q3 loss per share $0.23
November 7, 2016 / 9:42 PM / a year ago

BRIEF-Halozyme reports Q3 loss per share $0.23

Nov 7 (Reuters) - Halozyme Therapeutics Inc

* Halozyme reports third quarter 2016 financial results

* Q3 loss per share $0.23

* Q3 earnings per share view $-0.27 -- Thomson Reuters I/B/E/S

* Sees FY 2016 revenue $145 million to $150 million

* Q3 revenue $31.9 million versus I/B/E/S view $33.9 million

* Halozyme Therapeutics Inc sees FY 2016 cash flow of $75 million to $85 million

* FY2016 revenue view $148.8 million -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below